Brazil · Delayed Price · Currency is BRL Unipar Carbocloro Earnings Call Transcripts
Fiscal Year 2026
-
Surpassed all 2025 sustainability targets and completed major plant modernization, driving efficiency and cash generation despite lower international prices and challenging macro conditions. Strong cash position and disciplined CapEx set the stage for improved utilization and potential margin recovery in 2026.
Fiscal Year 2025
-
2025 saw record operational and financial results, driven by strategic Capex, cost reductions, and strong performance in chlorinated products, despite a challenging petrochemical cycle and volatile markets. Debt profile remains robust, with positive outlook for 2026.
-
Resilient performance delivered amid a challenging petrochemical cycle, with Q3 Adjusted EBITDA up 14% year over year and major CapEx projects nearing completion. Strong cash position, proactive debt management, and stable Chlor-alkali demand support future competitiveness.
-
Second quarter 2025 saw strong EBITDA and net profit growth despite industry headwinds, with cost reductions, full ramp-up of Camaçari, and strategic investments supporting resilience. Debt profile improved, and a major dividend was approved, while market volatility and compressed spreads persist.
-
Adjusted EBITDA rose 53% year-over-year to BRL 355 million, with strong cash generation and improved margins despite a weak petrochemical cycle and weather disruptions in Argentina. Major CapEx projects advanced, and leverage remained low at 0.88x.
Fiscal Year 2024
-
Record sales and robust EBITDA were achieved despite a challenging petrochemical cycle and Argentine economic contraction. Strategic investments, strong cash generation, and disciplined capital allocation supported resilience, with a positive outlook for operational efficiency and sustainable growth.
-
Q3 2024 saw strong financial recovery with EBITDA up 60% and net profit up 34% over Q2, driven by resilient demand, operational efficiency, and increased self-produced energy. Strategic investments and improved debt profile position the company for future growth.
-
Q2 2024 saw resilient performance amid global chemical downturn, with EBITDA of BRL 146M and net profit of BRL 89M. Strategic projects in Camaçari and Cubatão are progressing, and margin recovery is expected in Q3, supported by a strong business mix and solid cash position.